Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunpi Qiangshen Jingao is a Traditional Chinese Medicine (TCM) thick extract formulation primarily developed as a hospital preparation (internal preparation) by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine. It is specifically designed to treat pediatric conditions such as anorexia, malnutrition, and growth retardation by addressing the TCM syndrome of "Spleen and Kidney Deficiency" (Pi Shen Liang Xu). The formulation typically consists of a complex blend of herbs including *Astragalus membranaceus* (Huangqi), *Codonopsis pilosula* (Dangshen), and *Atractylodes macrocephala* (Baizhu), which work synergistically to improve digestive transport, enhance nutrient absorption, and support physical development. In clinical practice within China, it is recognized for its ability to improve appetite, increase body weight, and strengthen the immune constitution of children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yunpi qiangshen jingao.